Avient (AVNT)
(Delayed Data from NYSE)
$49.91 USD
+0.11 (0.22%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $49.92 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$49.91 USD
+0.11 (0.22%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $49.92 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
Avient (AVNT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 10.64% and 1.36%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
What Analyst Projections for Key Metrics Reveal About Avient (AVNT) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Avient (AVNT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
JMPLY or AVNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JMPLY vs. AVNT: Which Stock Is the Better Value Option?
FMC (FMC) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of -1.83% and 8.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.34% and 1.86%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ARKAY vs. AVNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
ARKAY vs. AVNT: Which Stock Is the Better Value Option?
Avient (AVNT) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Avient (AVNT) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Air Products and Chemicals (APD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Air Products and Chemicals (APD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Avient (AVNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
International Paper (IP) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
International Paper's (IP) Q3 results will likely reflect the ongoing weakness in packaging demand due to muted customer spending amid the inflationary scenario.
Linde (LIN) Gears up to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Linde's (LIN) Q3 earnings are expected to have benefited from higher industrial production during the quarter.
Why Avient (AVNT) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Avient (AVNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Chemical Stocks Worth a Bet Despite Demand Worries
by Anindya Barman
While the chemical industry is hamstrung by demand headwinds, the industry players are expected to benefit from strategic actions to boost performance. HWKN, KOP, KWR and AVNT are worth a look.
Are Investors Undervaluing Avient (AVNT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AVNT vs. AIQUY: Which Stock Is the Better Value Option?
by Zacks Equity Research
AVNT vs. AIQUY: Which Stock Is the Better Value Option?
Avient (AVNT) Declares Debt Paydown & Refinancing of Term Loan
by Zacks Equity Research
Avient (AVNT) pays off $100 million in existing term loans, bringing the total outstanding balance to $732 million.
Here's What Key Metrics Tell Us About Avient (AVNT) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Avient (AVNT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Avient (AVNT) Q2 Earnings Beat Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 3.28% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Avient (AVNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks to Watch on Dividend Hikes as Inflation Fears Linger
by Ritujay Ghosh
The J. M. Smucker Company (SJM), Avient Corporation (AVNT), AptarGroup, Inc. (ATR) and Conagra Brands, Inc. (CAG) recently hiked dividends.
Is Avient (AVNT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Avient (AVNT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Avient (AVNT) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Avient (AVNT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 14.55% and 0.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Koppers (KOP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Koppers (KOP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Avient (AVNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.